Tag

Novo Nordisk

Mads Krogsgaard Thomsen

Novo Nordisk to acquire Corvidia Therapeutics

June 18, 2020

Novo Nordisk has entered into …

Novo Nordisk CMC Development

Novo Nordisk announces Phase 2 results

June 16, 2020

Novo Nordisk announced results from …

Novo Nordisk defeat diabetes

Novo Nordisk launches new strategy to defeat diabetes

May 28, 2020

Novo Nordisk has announced the …

Novo Nordisk headquarters

Rybelsus approved for the treatment of adults with type 2 diabetes in the EU

April 16, 2020

Novo Nordisk has announced that …

Mads Krogsgaard Thomsen

Novo Nordisk’s Saxenda shows promising results

April 16, 2020

Novo Nordisk has announced that …

Novo Nordisk Haemophilia research

Novo Nordisk pauses trials in haemophilia A and B

April 7, 2020

Novo Nordisk has announced that …

Novo Nordisk Kalundborg

Novo Nordisk invests DKK 800 million in upgrading and expanding production facilities

February 11, 2020

Novo Nordisk has announced plans …

Mads Krogsgaard Thomsen

Novo Nordisk’s Ozempic approved in the US for CV risk reduction in people with type 2 diabetes and established CVD

January 16, 2020

Novo Nordisk has announced that …

Lars Fruergaard Joergensen

Novo Nordisk and UNICEF announce new partnership

November 27, 2019

Novo Nordisk and UNICEF have …

Novo Nordisk obtains worldwide licence to potential NASH candidate

November 11, 2019

Novo Nordisk and UBE Industries …

Novo Nordisk and bluebird bio in research agreement

October 14, 2019

The two companies have entered …

Mads Krogsgaard Thomsen

Novo Nordisk’s Rybelsus – the first GLP-1 in a tablet approved in the US

September 23, 2019

Novo Nordisk has announced that …

Novo Nordisk and Medtronic enter agreement

September 16, 2019

The two companies have announced …

Mads Krogsgaard Thomsen

Novo Nordisk’s Fiasp approved in Europe for adolescents and children

August 28, 2019

The European Commission has granted …

Lars Fruergaard Joergensen

Securities lawsuit filed in Denmark against Novo Nordisk

August 22, 2019

Novo Nordisk A/S has been …

Mads Krogsgaard Thomsen

Novo Nordisk’s Esperoct approved in the EU

June 24, 2019

The European Commission has granted …

1
2
3
···
7